SynthesisDrug design, development and therapy2015

A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer.

Changyuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.